AtriCure (ATRC) Tops Q1 EPS by 3c, Reiterates Prior Guidance For FY 2017

AtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.32), $0.03 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $41.3 million versus the consensus estimate of $40.3 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Nvidia and Broadcom earnings: TD Cowen says earnings won’t settle big questions
• VNET Group (VNET) Misses Q2 EPS by 164c